Actinium Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Actinium Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2011 to Q2 2024.
  • Actinium Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$12.4M, a 20.6% increase year-over-year.
  • Actinium Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$46.7M, a 3.33% increase year-over-year.
  • Actinium Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$51.9M, a 52.2% decline from 2022.
  • Actinium Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$34.1M, a 36.6% decline from 2021.
  • Actinium Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$25M, a 11.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$46.7M -$12.4M +$3.22M +20.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 -$49.9M -$9.6M +$1.99M +17.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 -$51.9M -$10.3M +$948K +8.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$52.9M -$14.4M -$4.55M -46.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$48.3M -$15.6M -$7.79M -99.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 -$40.5M -$11.6M -$6.42M -124% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 -$34.1M -$11.3M -$3.24M -40.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$30.9M -$9.8M -$3.33M -51.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$27.5M -$7.85M -$2.78M -54.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$24.8M -$5.16M +$208K +3.87% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$25M -$8.05M -$1.61M -25.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$23.4M -$6.47M -$856K -15.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$22.5M -$5.08M -$413K -8.86% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$22.1M -$5.37M +$311K +5.47% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$22.4M -$6.44M -$1.8M -38.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$20.6M -$5.61M +$1.04M +15.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$21.6M -$4.66M +$424K +8.34% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 -$22.1M -$5.68M +$16K +0.28% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$22.1M -$4.64M +$1.73M +27.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$23.8M -$6.65M -$455K -7.34% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-23
Q2 2019 -$23.3M -$5.09M -$173K -3.53% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$23.2M -$5.7M +$655K +10.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 -$23.8M -$6.36M -$1.16M -22.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-08
Q3 2018 -$22.7M -$6.2M +$498K +7.44% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$23.2M -$4.91M +$2.29M +31.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$25.5M -$6.35M +$1.45M +18.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$26.9M -$5.21M +$1.62M +23.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$28.5M -$6.7M +$406K +5.71% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$28.9M -$7.2M -$285K -4.13% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$28.7M -$7.81M -$1.8M -30% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$26.8M -$6.83M -$1.91M -38.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 -$24.9M -$7.1M -$2.46M -53% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$22.5M -$6.92M +$487K +6.57% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 -$23M -$6M +$1.86M +23.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$24.8M -$4.92M +$1.95M +28.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 -$26.8M -$4.64M +$2.41M +34.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 -$29.2M -$7.4M -$2.98M -67.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 -$26.2M -$7.87M -$3.73M -90.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$22.5M -$6.87M -$5.39M -363% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$17.1M -$7.04M -$5.44M -338% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 -$11.7M -$4.42M -$2.95M -200% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$8.71M -$4.14M -$2.12M -105% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$6.59M -$1.48M +$2.22M +59.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 -$8.81M -$1.61M +$790K +32.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 -$9.6M -$1.48M -$636K -75.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$8.96M -$2.02M -$1.02M -101% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$7.95M -$3.7M -$3.7M Oct 1, 2012 Dec 31, 2012 10-K 2014-02-28
Q3 2012 -$4.25M -$2.4M -$2.4M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$1.85M -$839K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 -$1.01M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$2.68K* Oct 1, 2011 Dec 31, 2011 10-Q 2012-04-23
Q3 2011 -$2.43K* Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.